We are live on
!
Find out more
VCG
Vantage Consulting Group Portfolio holdings
AUM
$19.7M
1-Year Est. Return
280.87%
This Fund
S&P 500
This Quarter
Est. Return
+17.65%
1 Year Est. Return
+280.87%
3 Year Est. Return
+261.08%
5 Year Est. Return
+180.34%
10 Year Est. Return
–
AUM
$1.23B
AUM Growth
–
Cap. Flow
+$1.06B
Cap. Flow
% of AUM
86.51%
Top 10 Holdings %
Top 10 Hldgs %
94.5%
Holding
1,884
New
1,883
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$911M |
| 2 |
ADC Therapeutics
ADCT
|
+$55.1M |
| 3 |
KYNB
Kyntra Bio
KYNB
|
+$25.5M |
| 4 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$5.96M |
| 5 |
Kroger
KR
|
+$366K |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 95.04% |
| 2 | Technology | 0.89% |
| 3 | Consumer Discretionary | 0.79% |
| 4 | Industrials | 0.61% |
| 5 | Consumer Staples | 0.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Exelon
EXC
$46.9B
| $246K | 0.02% |
+8,157
| New | +$241K |
|
27
McDonald's
MCD
$192B
| $245K | 0.02% |
+1,143
| New | +$249K |
|
28
Loews
L
$23.9B
| $243K | 0.02% |
+5,401
| New | +$217K |
|
29
TJX Companies
TJX
$174B
| $243K | 0.02% |
+3,555
| New | +$216K |
|
30
Yum! Brands
YUM
$42.2B
| $243K | 0.02% |
+2,237
| New | +$228K |
|
31
Berkshire Hathaway Class B
BRK.B
$1.1T
| $242K | 0.02% |
+1,044
| New | +$230K |
|
32
Xerox
XRX
$386M
| $242K | 0.02% |
+10,456
| New | +$221K |
|
33
Procter & Gamble
PG
$336B
| $241K | 0.02% |
+1,732
| New | +$242K |
|
34
Archer Daniels Midland
ADM
$38.2B
| $240K | 0.02% |
+4,763
| New | +$235K |
|
35
Church & Dwight Co
CHD
$23.4B
| $240K | 0.02% |
+2,754
| New | +$244K |
|
36
Colgate-Palmolive
CL
$73.1B
| $239K | 0.02% |
+2,794
| New | +$231K |
|
37
Domino's
DPZ
$11.5B
| $238K | 0.02% |
+620
| New | +$244K |
|
38
Clorox
CLX
$11.6B
| $237K | 0.02% |
+1,174
| New | +$243K |
|
39
Hormel Foods
HRL
$13.8B
| $234K | 0.02% |
+5,025
| New | +$245K |
|
40
Kimberly-Clark
KMB
$36.3B
| $234K | 0.02% |
+1,738
| New | +$243K |
|
|
TWTR
41
DELISTED
Twitter, Inc.
TWTR
| $223K | 0.02% |
+4,109
| New | +$196K |
|
42
Tyson Foods
TSN
$20.4B
| $221K | 0.02% |
+3,432
| New | +$213K |
|
43
Perrigo
PRGO
$1.4B
| $219K | 0.02% |
+4,886
| New | +$226K |
|
44
Meta Platforms (Facebook)
META
$1.42T
| $211K | 0.02% |
+772
| New | +$212K |
|
45
Aptiv
APTV
$12B
| $190K | 0.02% |
+1,457
| New | +$162K |
|
46
BorgWarner
BWA
$13.1B
| $188K | 0.02% |
+5,528
| New | +$187K |
|
|
FLIR
47
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
| $188K | 0.02% |
+4,286
| New | +$165K |
|
48
Monster Beverage
MNST
$94.3B
| $187K | 0.02% |
+4,040
| New | +$170K |
|
49
Cadence Design Systems
CDNS
$93.6B
| $184K | 0.02% |
+1,348
| New | +$158K |
|
50
Coca-Cola
KO
$377B
| $183K | 0.01% |
+3,330
| New | +$172K |
|
Similar funds
MVG
NCM
FFGIM
PIM
HFG
SWM
ICM
SM
Vantage Consulting Group's Q4 2020 Portfolio in Review
Q4 2020 is the first quarter with a 13F filing on record for Vantage Consulting Group, which disclosed 1,884 positions worth $1.23B. Its ten largest holdings account for 94% of the portfolio.
Its largest position is Royalty Pharma: 21,477,282 shares worth $1.07B.
By sector, the portfolio is most concentrated in Healthcare at 95% of assets, followed by Technology and Consumer Discretionary.
- Vantage Consulting Group's largest Q4 2020 buy was Royalty Pharma: 21,477,282 shares worth $1.07B.
- Vantage Consulting Group's ten largest holdings make up 94% of its $1.23B portfolio in Q4 2020.
- Vantage Consulting Group disclosed 1,884 positions in Q4 2020, its first 13F filing on record.
Based on Vantage Consulting Group's 13F filing for Q4 2020, filed 12 Feb 2021.